Paravalvular leak (PVL) is a frequent complication of transcatheter aortic valve replacement
(TAVR) and is seen at a much higher rate after TAVR than after conventional surgical aortic …

The question may be asked why another Guideline manuscript is needed. The reasons are
fivefold:(1) to outline pros and cons of treatment options;(2) to outline areas where further …

Stroke is a potential complication of treating patients with aortic stenosis via surgical aortic
valve replacement (AVR), transcatheter aortic valve replacement (TAVR), and balloon aortic …

Background Previous trials have shown that among high-risk patients with aortic stenosis,
survival rates are similar with transcatheter aortic-valve replacement (TAVR) and surgical …

Background Among patients with aortic stenosis who are at intermediate or high risk for
death with surgery, major outcomes are similar with transcatheter aortic-valve replacement …

Background The use of transcatheter aortic-valve replacement has been shown to reduce
mortality among high-risk patients with aortic stenosis who are not candidates for surgical …

Background The Placement of Aortic Transcatheter Valves (PARTNER) trial showed that
among high-risk patients with aortic stenosis, the 1-year survival rates are similar with …

Emerging data suggest that a subset of circulating human CD34+ cells have phenotypic
features of endothelial cells. Whether these cells are sloughed mature endothelial cells or …

Background Although transcatheter aortic-valve replacement (TAVR) is an accepted
alternative to surgery in patients with severe aortic stenosis who are at high surgical risk …

Summary Background The Placement of Aortic Transcatheter Valves (PARTNER) trial
showed that mortality at 1 year, 2 years, and 3 years is much the same with transcatheter …